Profiel
James A.
Meer has been Senior Vice President, Chief Financial Officer, Secretary and Treasurer of Pharmos Corp.
since January 2005.
He has been Senior Vice President, Chief Financial Officer and Treasurer of Columbia Laboratories, Inc. since December 2006.
Mr. Meer was Vice President, Chief Financial Officer, Secretary and Treasurer of Pharmos from July 2004 to January 2005.
From November 2000 to July 2004, he was Principal of Meer Healthcare Consulting and GreyPeach Partners.
From 1992 to 2000, Mr. Meer was Vice President and Treasurer of Schein Pharmaceutical, Inc. He has over 35 years of financial experience including 15 years in the life sciences industry.
Mr. Meer held various senior financial positions at EnviroSource, Inc., John Labatt Ltd.
and General Host Corp.
He received an MBA degree in Finance from Pace University and a BA degree in Economics from Rutgers College.
Eerdere bekende functies van James A. Meer
| Bedrijven | Functie | Einde |
|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Director of Finance/CFO | 11-05-2009 |
| W WORL | Director of Finance/CFO | 01-01-2006 |
| Schein Pharmaceutical, Inc. | Treasurer | - |
Opleiding van James A. Meer
| Rutgers State University of New Jersey | Undergraduate Degree |
| Pace University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| W WORL | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
| Schein Pharmaceutical, Inc. | Health Technology |
